Reduce tremor with vibrotactile stimulation
- Trial ID
- NCT05830110
- Official Title
- Patterned Multichannel Vibrotactile Stimulation for the Longitudinal Treatment of Moderate Stage Parkinson's Disease
- Goal
- Reduce tremor with vibrotactile stimulation
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Synergic Medical Technologies, Inc.
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson's Disease
- Interventions
- Active Vibrotactile Coordinated Reset, Sham vibrotactile coordinated reset
Plain-Language Summary
The goal is to reduce motor problems like tremor, stiffness, and slowness by disrupting the abnormal synchronized brain rhythms that contribute to moderate Parkinson's symptoms. The approach uses a noninvasive device that delivers patterned, multichannel vibrations to the skin in a "coordinated reset" pattern to desynchronize overactive neural circuits, it is tested against a sham device and does not contain drugs so it does not directly interact with levodopa, although improving neural rhythms could reduce symptoms people treat with medication. About 30 people aged 45 to 90 with bilateral, moderate idiopathic Parkinson's who can undergo EEG procedures are being sought, and anyone on dopamine agonists with compulsive behaviors is excluded.
Locations
- Synergic Medical Technologies, Eugene, Oregon, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Active Vibrotactile Coordinated Reset. The goal is to reduce motor problems like tremor, stiffness, and slowness by disrupting the abnormal synchronized brain rhythms that contribute to moderate Parkinson's symptoms. The approach uses a noninvasive device that delivers patterned, multichannel vibrations to the skin in a "coordinated reset" pattern to desynchronize overactive neural circuits, it is tested against a sham device and does not contain drugs so it does not directly interact with levodopa, although improving neural rhythms could reduce symptoms people treat with medication. About 30 people aged 45 to 90 with bilateral, moderate idiopathic Parkinson's who can undergo EEG procedures are being sought, and anyone on dopamine agonists with compulsive behaviors is excluded.
- Who can participate?
- Participants must be between 45 Years and 90 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 9 months.